A team of physicians studied the success rate of dental implants among patients who have serious cases of bone loss, namely osteoporosis, to the point of taking bisphosphonates like Fosamax® (focus of the study) and Actonel®. These drugs work by slowing down the rate of osteonecrosis or bone loss.
The reason behind dental implants being relative to this study is because bone loss can also affect the jaw, which is called osteonecrosis of the jaw (ONJ). In addition, doctors believe that ONJ is a side effect of taking bisphosphonates despite the chances of triggering being low. The study aims to find out if implants can survive in an environment teeming with the drug.